Study of Novel Treatment Combinations in Patients With Lung Cancer

NCT05633667 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer
Advanced or Metastatic Non-Small-Cell Lung Cancer
Resectable Non-Small-Cell Lung Cancer

Interventions

DRUG: Zimberelimab (ZIM)
DRUG: Domvanalimab (DOM)
DRUG: Sacituzumab govitecan-hziy (SG)
DRUG: Etrumadenant (ETRUMA)
DRUG: Carboplatin
DRUG: Cisplatin
DRUG: Pemetrexed
DRUG: Paclitaxel
DRUG: Nab-paclitaxel
DRUG: Docetaxel
DRUG: Nivolumab

Sponsor

Gilead Sciences

Collaborators

[object Object]